GAIN
Q4 2026 EPS Estimate
$0.22
Nov 3, 2026 · Reports after close
Revenue Estimate
$26M
FY2027E EPS$1.01
FY2028E EPS$1.01

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
57
Score
2 Buy (29%)5 Hold (71%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
229%
Hold
571%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$17.00
+3.0%
Consensus
$17.00
+3.0%
Bull
$17.00
+3.0%
12-Month Target Range7 analysts
$17.00$17.00$17.00
Current $16.51Consensus
Current Price
$16.51
Upside to Consensus
$0.49

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+8.16%
EPS+148.77%
FY2028
Rev+6.16%
EPS+0.50%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2027EFY2028E
Revenue Avg$108M$114M
Low$107M$112M
High$109M$117M
EBITDA Avg$96M$102M
Low$95M$99M
High$97M$104M
EBIT Avg$91M$96M
Low$90M$94M
High$91M$98M
Net Income Avg$42M$41M
Low$36M$36M
High$42M$44M
EPS Avg$1.01$1.01
Low$0.92$0.93
High$1.09$1.15
Analysts (Rev / EPS)3 / 23 / 3
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028
Revenue Avg$26M$27M$27M$28M$28M$29M$29M
Low$26M$26M$26M$27M$27M$28M$28M
High$26M$27M$28M$29M$29M$30M$30M
EBITDA Avg$23M$24M$24M$25M$25M$26M$26M
Low$23M$23M$23M$24M$24M$24M$25M
High$23M$24M$25M$26M$26M$26M$27M
EBIT Avg$22M$22M$23M$24M$24M$24M$24M
Low$22M$22M$22M$23M$23M$23M$23M
High$22M$23M$23M$24M$25M$25M$25M
Net Income Avg$10M$8M$9M$10M$10M$10M$10M
Low$10M$8M$9M$9M$9M$10M$10M
High$10M$9M$9M$10M$10M$11M$11M
EPS Avg$0.25$0.21$0.23$0.25$0.25$0.26$0.26
Low$0.24$0.19$0.21$0.24$0.24$0.24$0.24
High$0.26$0.22$0.24$0.26$0.26$0.26$0.27
Analysts (Rev / EPS)3 / 33 / 31 / 11 / 11 / 11 / 11 / 2

Earnings Surprises

Recent Analyst Actions

May 14, 2026Oppenheimer
Gladstone Investment price target raised to $17 from $15 at Oppenheimer
Target:$17.00
+1.9%from $16.68
Feb 4, 2026Oppenheimer
Gladstone Investment price target raised to $15 from $14 at Oppenheimer
Target:$15.00
+5.0%from $14.29
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.